1/12/2023Information Collection on the 8th VBP Officially Initiated

1/12/2023Astellas Sues Qilu Pharma in the U.S. to Block Its Generic Bladder Dru...

1/12/2023MNC Incubators in China (PharmaDJ)

1/11/2023Merck to Take Legal Action against Unauthorized Distributors of Its C...

1/11/2023Merck's Covid Drug Molnupiravir Could Be Available in China Soon: Sino...

1/11/2023Hepalink Invests $60M with TPG Biotechnology fund

1/10/2023AmMax and Evopoint Enter into an Exclusive Option Agreement to License...

1/9/2023NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...

1/9/2023Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...

1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...

1/6/2023Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)

1/6/2023Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)

1/6/2023CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...

1/6/2023CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11

1/6/2023China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...

1/6/2023Recent Executive Moves

1/5/2023GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...

1/5/2023CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...

1/5/2023NMPA Holds National Drug Regulatory Conference in Beijing

1/5/20232022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...

1/5/2023Aurisco to Build Oligonucleotides Manufacturing Facility in China

1/5/202320 Promising New Drugs Anticipated To Be Approved in China 2023 (Pharm...

1/4/2023NHC and SATCM Announce Action Plan for the Overall Pain Management Tri...

1/3/2023Fosun Pharma and Henlius Entered into an Exclusive License Agreement f...

12/30/2022Merck's COVID Drug Molnupiravir Conditionally Approved in China

12/30/2022Abbott to Exit China's Pediatric Nutrition Market

12/30/2022Recent Executive Moves

12/30/2022Financial-related Company News Digest (December 2022)

12/29/2022NMPA Participates in the CIMDR - GHWP Session & International Drug Reg...

12/29/2022NMPA Issues the Provisions on Facilitating Main Responsibility of MAHs...

Page:59/361 Total number of articles:10805: [First][<<] [57] [58] [59] [60] [61] [>>] [End]